Clinical Trial Update: Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

View source ↗

Summary

This clinical trial update discusses the role of gene molecular alterations as prognostic markers in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: NSCLC (Non-small Cell Lung Cancer) | Status: ACTIVE_NOT_RECRUITING